Inhibition of arginase in rat and rabbit alveolar macrophages by N(ω)-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase

British Journal of Pharmacology

Volumn 121, Issue 3, 1997, Pages 395-400

  Hey, Claudia ^a   Boucher, Jean Luc ^b   Vadon Le Goff, Sandrine ^b   Ketterer, Gabi ^a   Wessler, Ignaz ^c   Racké, Kurt ^a  

^a UNIVERSITY OF BONN   (Germany)

^b CNRS   (France)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Airway inflammation; Alveolar macrophages; Arginase; L arginine metabolism; N( ) hydroxy D,L indospicine; Nitric oxide; Nitric oxide synthase

Indexed keywords

4 HYDROXYAMIDINOPHENYLALANINE; ARGINASE; ARGININE; BACTERIUM LIPOPOLYSACCHARIDE; CITRULLINE; ENZYME INHIBITOR; N OMEGA HYDROXYINDOSPICINE; NITRIC OXIDE SYNTHASE; ORNITHINE; PHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG;

AIRWAY; AMINO ACID METABOLISM; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; INFLAMMATION; LIVER; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RABBIT; RAT;

ANIMALS; ARGINASE; ARGININE; FEMALE; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030975894     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701143     Document Type: Article

References (32)

1. BOGLE, R.G., BAYDOUN, A.R., PEARSON, J.D. & MANN, G.E. (1996). Regulation of L-arginine transport and nitric oxide release in superfused porcine aortic endothelial cells. J. Physiol., 490, 229-241.
2. BOGEE, R.G., BAYDOUN, A.R., PERASON, J.D., MONCADA, S. & MANN, G.E. (1992). L-Arginine transport is increased in macrophages generating nitric oxide. Biochem. J., 284, 15-18.
3. ω-Hydroxy-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem. Biophys. Res. Commun., 203, 1614-1621.
4. 2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun., 206, 667-673.
5. CURIE, G.A. (1978). Activated macrophages kill tumour cells by releasing arginase. Nature, 273, 758-759.
6. ω-hydroxyamino-α-amino acids as new class of very strong inhibitors of arginases. J. Biol. Inorg. Chem., 1, 73-82.
7. G-hydroxy-L-arginine: implications for the regulation of nitric oxide biosynthesis by arginase. Biochem. Biophys. Res. Commun., 202, 74-179.
8. DENIS, M. (1994). Human monocytes/macrophages: NO or no NO? J. Leukocyte Biol., 55, 682-684.
9. DUGAS, B., MOSSALAYI, M.D., DAMAIS, C. & KOLB, J.-P. (1995). Nitric oxide production by human monocytes: evidence for a role in CD23. Immunology Today, 16, 574-580.
10. G-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett., 359, 251-254.
11. HERZFELD, A. & RAPER, S.M. (1976). The heterogenicity of arginases in rat tissues. Biochem. J., 153, 469-478.
12. HEVEL, J.M., WHITE, K.A. & MARLETTA, M.A. (1991). Purification of the inducible murine macrophage nitric oxide synthase: identification as a flavoprotein. J. Biol. Chem., 266, 22789-22791.
13. ω-OH-D,L-Indospicine, a potent and selective inhibitor of arginase in rat and rabbit alveolar macrophages can promote utilization of L-arginine by nitric oxide synthase. Br. J. Pharmacol., (in press).
14. HEY, C., CEBULLA, G., STICHNOTE, C., WESSLER, I. & RACKÉ, K. (1996b). Differential role of protein kinase C and cAMP-dependent pathways in the control of L-arginine uptake in rabbit alveolar macrophages. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, R7.
15. HEY, C., WESSLER, I. & RACKÉ, K. (1995). Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 651-659.
16. HOFMANN, F., KREUSCH, J., MAIER, K.P., MUNDER, P.G. & DECKER, K. (1978). The urea cycle in different types of macrophages. Biochem. Soc. Trans., 6, 990-993.
17. HOLT, P.G. (1979). A simple technique for the preparation of high numbers of viable alveolar macrophages from small laboratory animals. J. Immunol. Methods, 27, 189-198.
18. JENKINSON, C.P., GRODY, W.W. & CEDERBAUM, S.D. (1996). Comparative properties of arginases. Comp. Biochem. Physiol. B - Biochem. & Mol. Biol., 114, 107-132.
19. JORENS, P.G., VAN OVERFELD, F.J., BULT, H., VERMEIRE, P.A. & HERMAN, A.G. (1991). L-Arginine-dependent production of nitrogen oxides by rat pulmonary macrophages. Eur. J. Pharmacol., 200, 205-209.
20. KAYSEN, G.A. & STRECKER, H.J. (1973). Purification and properties of arginase of rat kidney. Biochem. J., 133, 779-788.
21. MEIJER, A.J., LAMERS, W.H., CHAMULEAU, R.A.F.M. (1990). Nitrogen metabolism and ornithine cycle function. Physiol. Rev., 70, 701-748.
22. MODOLELL, M., CORRALIZA, I.M., LINK, F., SOLER, G. & EICHMANN, K. (1995). Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol., 25, 1101-1104.
23. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-134.
24. NEMATHOLAHI, H., WESSLER, I. & RACKÉ, K. (1995). Forskolin induces de-novo synthesis of arginase in rabbit alveolar macrophages. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, R79.
25. NOZAKI, Y., ISOBE, K.K., NAKASHIMA, I. & SHIMOKATA, K. (1993). Tumor cytotoxicity of nitric oxide produced from alveolar macrophages directly stimulated with tumor cells. Int. J. Oncol., 2, 1053-1057.
26. RICK, W. (1974). Klinische Chemie und Mikroscopie. Berlin, Heidelberg, New York: Springer.
27. SATO, H., FUJIWARA, M. & BANNAI, S. (1992). Effect of lipopolysaccharide on transport and metabolism of arginine in mouse peritoneal macrophages. J. Leukocyte Biol., 52, 161-164.
28. STUEHR, D.J, CHO, H.J., KWON, N.S., WEISE, M.F. & NATHAN, C.F. (1991). Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc. Natl. Acad. Sci. U.S.A., 88, 7773-7777.
29. ω-hydroxyarginine, Nω-hydroxyindospicine and p-hydroxyamidinophenylalanine. J. Chem. Soc. Perkin Trans., 1, 645-648.
30. WANG, W.W., JENKINSON, C.P., GRISCAVAUE, J.M., KERN, R.M., ARABOLOS, N.S., BYRNS, R.E., CEDERBAUM, S.D. & IGNARRO, L.J. (1995). Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem. Biophys. Rex. Commun., 210, 1009-1016.
31. WHITE, M.F. (1985). The transport of cationic amino acids across the plasma membrane of mammalian cells. Biochim. Biophys. Acta, 822, 355-374.
32. YUI, Y., HATTORI, R., KOSUGA, K., EIZAWA, H., HIKI, K. & KAWAI, C. (1991). Purification of nitric oxide synthase from rat macrophages. J. Biol. Chem., 266, 12544-12547.